1 |
下肢动脉粥样硬化性疾病诊治中国专家建议(2007)写作组, 中华医学会老年医学分会, 中华医学会心血管病学分会, 等. 下肢动脉粥样硬化性疾病诊治中国专家建议(2007) [J]. 中华老年医学杂志, 2007, 26(10): 725-740.
|
2 |
Campia U, Gerhard-Herman M, Piazza G, et al. Peripheral artery disease: past, present, and future [J]. Am J Med, 2019, 132(10):1133-1141.
|
3 |
Kullo IJ, Rooke TW, Practice C. Peripheral artery disease [J]. N Engl J Med, 2016, 374(9): 861-871.
|
4 |
李亚玉, 王曈, 曲青霞, 等. 下肢动脉粥样硬化与急性冠脉综合征的关系研究 [J]. 实用心脑肺血管病杂志, 2021, 29(5): 23-28.
|
5 |
涂振兴, 王艳, 李烨, 等. 2型糖尿病患者中性粒细胞/淋巴细胞比值、单核细胞/高密度脂蛋白比值与下肢动脉病变的相关性 [J]. 临床合理用药杂志, 2021, 14(15): 38-41.
|
6 |
Haybar H, Pezeshki SMS, Saki N. Evaluation of complete blood count parameters in cardiovascular diseases: An early indicator of prognosis? [J]. Exp Mol Pathol, 2019, 110: 104267.
|
7 |
Liu H, Liu J, Zhao H, et al. The design andrationale of the Beijing Vascular Disease Patients Evaluation Study(BEST study) [J]. Contemp Clin Trials Commun, 2017, 7: 18-22.
|
8 |
Aboyans V, Ricco JB, Bartelink MEL, et al; Scientific Document GroupESC. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European stroke organization (ESO) the task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS) [J]. Eur Heart J, 2018, 39(9): 763-816.
|
9 |
骆雷铭. 外周动脉疾病的研究进展与前景 [J]. 中华老年心脑血管病杂志, 2018, 20(5): 449-453
|
10 |
王雪琦, 赵斓婷, 马春燕. 颈动脉及下肢动脉粥样硬化与冠心病相关性的研究进展 [J]. 实用临床医药杂志, 2022, 26(3): 125-129.
|
11 |
Haybar H, Pezeshki SMS, Saki N. Evaluation of complete blood count parameters in cardiovascular diseases: An early indicator of prognosis? [J]. Exp Mol Pathol, 2019, 110: 104267.
|
12 |
Ganjali S, Gotto AMJr, Ruscica M, et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases [J]. J Cell Physiol, 2018, 233(12): 9237-9246.
|
13 |
Balta S, Celik T, Mikhailidis DP, et al. The relation between atherosclerosis and the neutrophil-lymphocyte ratio [J]. Clin Appl Thromb Hemost, 2016, 22(5): 405-411.
|
14 |
Döring Y, Soehnlein O, Weber C. Neutrophil extracellular traps in atherosclerosis and atherothrombosis [J]. Circ Res, 2017, 120(4): 736-743.
|
15 |
Ndrepepa G. Myeloperoxidase -A bridge linking inflammation and oxidative stress with cardiovascular disease [J]. Clin Chim Acta, 2019, 493:36-51.
|
16 |
Qin S. LDL and HDL Oxidative modification and atherosclerosis [J]. Adv Exp Med Biol, 2020, 1276: 157-169.
|
17 |
Huang JB, Chen YS, Ji HY, et al. Neutrophil to high-density lipoprotein ratio has a superior prognostic value in elderly patients with acute myocardial infarction: a comparison study [J]. Lipids Health Dis, 2020, 19(1): 59.
|
18 |
刘著, 吴世政, 樊青俐, 等. 中性粒细胞和单核细胞与高密度脂蛋白胆固醇比值对不同海拔动脉粥样硬化狭窄的预测 [J]. 中华老年心脑血管病杂志, 2021, 23(10): 1073-1076.
|
19 |
Núñez J, Miñana G, Bodí V, et al. Low lymphocyte count and cardiovascular diseases [J]. Curr Med Chem, 2011, 18(21): 3226-333.
|
20 |
Mendes-Pinto D, Rodrigues-Machado MDG. Applications of arterial stiffness markers in peripheral arterial disease [J]. J Vasc Bras, 2019, 18: e20180093.
|
21 |
Ato D. Brachial-ankle pulse wave velocity, cardio-ankle vascular index, and prognosis [J]. Vasc Health Risk Manag, 2018, 14: 321-348.
|
22 |
Bevan GH, White Solaru KT. Evidence-based medical management of peripheral artery disease [J]. ArteriosclerThrombVasc Biol, 2020, 40(3): 541-553.
|
23 |
王宏宇, 刘欢. 推动心脏和血管健康规范化综合评估,增强全民血管健康意识-《中国血管健康评估系统应用指南(2018第三次报告)》解读 [J]. 中华医学杂志, 2018, 98(37): 2953-2954.
|
24 |
张颖怡, 刘金波, 刘欢, 等. 全身动脉粥样硬化斑块与脑梗死的关系: 北京血管病变评价研究结果 [J]. 心血管病学进展, 2021, 42(3): 277-284.
|